US Stock Insider Trading | United Treatment disclosed 4 insider trading transactions on February 24

K-LinePoet · 2026-03-05T02:28:57+00:00

On February 24, 2026, United Therapeutics disclosed multiple transactions by executive BENKOWITZ MICHAEL on February 23, including the purchase of 9,375 shares and the sale of 14,000 shares. The company focuses on addressing the medical needs of patients with chronic diseases, with primary revenue coming from sales of Remodulin, Tyvaso, and Tadalafil.

K-LinePoet

2026-03-05 02:28:57

Abstract generation in progress

On February 24, 2026, United Therapeutics (UTHR) disclosed four insider transactions. Executive BENKOWITZ MICHAEL purchased 9,375 shares on February 23, 2026.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
February 24, 2026	Executive	BENKOWITZ MICHAEL	February 23, 2026	Buy	9,375	117.76	$1,104,000
February 24, 2026	Executive	BENKOWITZ MICHAEL	February 23, 2026	Buy	5,065	146.03	$739,600
February 24, 2026	Executive	BENKOWITZ MICHAEL	February 23, 2026	Sell	14,000	472.13	$6,817,500
February 19, 2026	Executive	MAHON PAUL A	February 19, 2026	Sell	2,100	478.15	$1,004,100
February 19, 2026	Executive	MAHON PAUL A	February 19, 2026	Buy	8,300	146.03	$1,212,000
February 19, 2026	Executive	MAHON PAUL A	February 19, 2026	Sell	1,114	477.10	$531,500
February 19, 2026	Executive	MAHON PAUL A	February 19, 2026	Sell	288	473.23	$136,300
February 19, 2026	Executive	MAHON PAUL A	February 19, 2026	Sell	616	471.36	$290,400
February 19, 2026	Executive	MAHON PAUL A	February 19, 2026	Sell	775	472.76	$366,000
February 19, 2026	Executive	MAHON PAUL A	February 19, 2026	Sell	1,059	475.09	$503,100

[Company Profile]

United Therapeutics Corporation was founded in Delaware in 1996. It is a biotechnology company dedicated to developing and commercializing unique products that address unmet medical needs for patients with chronic and life-threatening conditions. Its revenue mainly comes from sales of Remodulin, Tyvaso, and Tadalafil. Their marketing and sales teams work hard to ensure their products are available in authorized countries, primarily through their professional distributors in the U.S. and other international distributors.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.